3. For whom we create added value
In this chapter, we first look at the added value the innovative biopharmaceutical sector creates for patients, the healthcare system, and society through the new medicines and vaccines it develops and brings to market. we have selected four striking examples and also examine the importance of value-based pricing for these innovations.
Our sector is also a cornerstone of Belgium’s knowledge economy, as shown by the strong figures on employment, exports, production, added value, and investment in 2024. this is further illustrated by the positive cost–benefit analysis of our sector for the Belgian government.